Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Yoshida

Showing results (331-340 of 337) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 337 results.
The Kurume Medical Journal|November 27, 2024
Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal ReactionHironori Akiyama, Ken Yoshida, Tadayuki Kotsuma, et al.
Radiation Oncology (London, England)|June 5, 2015
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assuranceYuki Otani, Takayuki Nose, Takushi Dokiya, et al.
Japanese Journal of Radiology|May 6, 2017
Uncertainty of cosmetic evaluation after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility studyEisaku Yoden, Takayuki Nose, Yuki Otani, et al.
Brachytherapy|February 23, 2017
Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT ConsortiumHiromichi Ishiyama, Nobuhiko Kamitani, Hidemasa Kawamura, et al.
Japanese Journal of Clinical Oncology|April 26, 2022
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trialNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Journal of Gynecologic Oncology|January 5, 2023
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancerNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Cell|April 30, 2021
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseasesMineto Ota, Yasuo Nagafuchi, Hiroaki Hatano, et al.
Pageof 34

Showing results (331-340 of 337) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 337 results.
The Kurume Medical Journal|November 27, 2024
Validity of High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Mobile Tongue Cancer in Terms of the Acute Mucosal ReactionHironori Akiyama, Ken Yoshida, Tadayuki Kotsuma, et al.
Radiation Oncology (London, England)|June 5, 2015
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assuranceYuki Otani, Takayuki Nose, Takushi Dokiya, et al.
Japanese Journal of Radiology|May 6, 2017
Uncertainty of cosmetic evaluation after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility studyEisaku Yoden, Takayuki Nose, Yuki Otani, et al.
Brachytherapy|February 23, 2017
Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT ConsortiumHiromichi Ishiyama, Nobuhiko Kamitani, Hidemasa Kawamura, et al.
Japanese Journal of Clinical Oncology|April 26, 2022
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trialNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Journal of Gynecologic Oncology|January 5, 2023
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancerNaoya Murakami, Miho Watanabe, Takashi Uno, et al.
Cell|April 30, 2021
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseasesMineto Ota, Yasuo Nagafuchi, Hiroaki Hatano, et al.
Pageof 34